subslover
1 year ago
Asensus Surgical Announces Collaboration with NVIDIA to Enhance Augmented Intelligence Capabilities of the ISU
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced a collaboration with NVIDIA to accelerate the development of Asensusโs Intelligent Surgical Unit™ (ISU™) and improve its ability to deliver novel clinical intelligence to surgeons.
Asensus will utilize a broad suite of NVIDIA tools to enhance the augmented intelligence capabilities of its ISU. Asensusโs ISU is built with NVIDIA accelerated computing technology and has been bringing real-time augmented intelligent features โ such as digital tags, 3D measurement, and enhanced camera control โ to surgeons since 2021.
โWeโre thrilled to collaborate with NVIDIA to enhance the machine vision and image analytics capabilities of the ISU, as well as the processing speed and precision of its augmented intelligence capabilities. Utilizing NVIDIAโs advanced technologies will allow us to further improve the ISUโs augmented intelligence capabilities and the roadmap of our innovative clinical applications,โ said Anthony Fernando, Asensus Surgical President and CEO. โThrough this collaboration, Asensus is furthering its vision to enhance clinical intelligence in surgery through the use of advanced augmented intelligence tools.โ
As part of the collaboration, both companies will have early access to relevant product roadmaps, fostering synergistic development. Furthermore, Asensus and NVIDIA plan to jointly define innovative business models for the development, deployment, and commercialization of digital surgical solutions.
โThe healthcare industry, and in particular digital surgery, is becoming one of the largest data generating industries. NVIDIA brings a domain-specific full stack edge AI computing platform, Holoscan, to medtech innovators looking to optimize real-time data and image processing to help solve complex problems and improve surgeon decision-making,โ said David Niewolny, Director of Healthcare Business Development at NVIDIA. โAs a leading FDA cleared solution in soft-tissue abdominal surgery, Asensusโs ISU is a perfect platform to leverage NVIDIAโs software-defined architecture to accelerate innovation and deliver new products to surgeons faster via software-as-a-medical-device applications.โ